200 related articles for article (PubMed ID: 23108602)
1. Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores.
Carvalho CG; Ribeiro MR; Bonilha MM; Fernandes M; Procianoy RS; Silveira RC
J Pediatr (Rio J); 2012; 88(6):465-70. PubMed ID: 23108602
[TBL] [Abstract][Full Text] [Related]
2. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
[TBL] [Abstract][Full Text] [Related]
3. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU).
Jobanputra N; Save SU; Bavdekar SB
Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245
[TBL] [Abstract][Full Text] [Related]
4. Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study.
Oguz SS; Kanmaz HG; Dilmen U
Int J Clin Pharm; 2012 Feb; 34(1):136-41. PubMed ID: 22234653
[TBL] [Abstract][Full Text] [Related]
5. The Unlicensed and Off-label Prescription of Medications in General Paediatric Ward: An Observational Study.
Dornelles AD; Calegari LH; de Souza L; Ebone P; Tonelli TS; Carvalho CG
Curr Pediatr Rev; 2019; 15(1):62-66. PubMed ID: 30421680
[TBL] [Abstract][Full Text] [Related]
6. USE OF OFF-LABEL MEDICATIONS IN A NEONATAL INTENSIVE CARE UNIT.
Koszma EIA; Bispo AJB; Santana IAO; Santos CNODBD
Rev Paul Pediatr; 2021; 39():e2020063. PubMed ID: 33440406
[TBL] [Abstract][Full Text] [Related]
7. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
[TBL] [Abstract][Full Text] [Related]
8. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
9. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
[TBL] [Abstract][Full Text] [Related]
10. [Use of off-label drugs in neonatal intensive care].
Sucasas Alonso A; Avila-Alvarez A; Combarro Eiriz M; Martínez Roca C; Yáñez Gómez P; Codias López A; Fernández Trisac JL; Pértega Díaz S
An Pediatr (Engl Ed); 2019 Oct; 91(4):237-243. PubMed ID: 30772271
[TBL] [Abstract][Full Text] [Related]
11. [Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines].
Costa HTML; Florencio AP; Bezerra PKDV; Cavalcanti JEC; Costa TX; Fernandes FEM; Martins RR
An Pediatr (Engl Ed); 2021 Mar; 94(3):153-160. PubMed ID: 33514478
[TBL] [Abstract][Full Text] [Related]
12. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
Lee JL; Redzuan AM; Shah NM
Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
[TBL] [Abstract][Full Text] [Related]
13. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT
Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504
[TBL] [Abstract][Full Text] [Related]
14. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study.
Mazhar F; Akram S; Haider N; Hadi MA; Sultana J
Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741
[TBL] [Abstract][Full Text] [Related]
15. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
16. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.
Arocas Casañ V; Cabezuelo Escribano B; Garrido-Corro B; De la Cruz Murie P; Blázquez Álvarez MJ; De la Rubia Nieto MªA
Farm Hosp; 2017 May; 41(3):371-381. PubMed ID: 28478751
[TBL] [Abstract][Full Text] [Related]
17. [Justification of off-label antibiotics uses in hospitalized children].
Berthod C; Kassaï B; Boussageon R; ; Adelaide L; Jacquet-Lagrèze M; Lajoinie A
Therapie; 2017 Dec; 72(6):649-658. PubMed ID: 28647107
[TBL] [Abstract][Full Text] [Related]
18. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
[TBL] [Abstract][Full Text] [Related]
19. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
Ellul IC; Grech V; Attard-Montalto S
Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
[TBL] [Abstract][Full Text] [Related]
20. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
Kieran EA; O'Callaghan N; O'Donnell CP
Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]